TACROLIMUS - ANVISA Registration 10287411026

Access comprehensive regulatory information for TACROLIMUS in Brazil's medical device market through Pure Global AI's free database. This Risk Class III medical device is registered under ANVISA number 10287411026 and manufactured by manufacturer not specified. The registration is held by ROCHE DIAGNÓSTICA BRASIL LTDA with validity until Dec 02, 2033.

This page provides complete technical specifications for 2 related devices, regulatory compliance details, 5 similar products found using AI-powered semantic search, 5 companies making the same product including SIEMENS HEALTHCARE DIAGNOSTICS INC, SHENZHEN NEW INDUSTRIES BIOMEDICAL ENGINEERING CO., LTD., and 5 recent registrations in the same technical category. Pure Global AI offers free access to over 100,000+ Brazilian medical device registrations, helping global MedTech companies navigate ANVISA regulations, identify competitors, and discover partnership opportunities efficiently.

Free Database
Powered by Pure Global AI
100,000+ Devices
5 Similar Products
5 Competitors
10287411026
2 Related Devices
Registration Details
ANVISA Registration Number: 10287411026
Janaina dos Santos de Miranda

Janaina dos Santos de Miranda

🇧🇷 Brazil Regulatory Expert

Need help with your Brazil registration?

Contact Pure Global Brazil Team
Free consultation

Related Devices (2)

Tacrolimus Calset
Risk Class III

Registration Details

10287411026

25351596880201344

30280358000186

Company Information

Dates and Status

Dec 02, 2013

02/12/2033

09/18/2025 19:00:01

Tacrolimus Calset
Risk Class III

Registration Details

10287411026

25351596880201344

30280358000186

Company Information

Germany
PT: ALEMANHA

Dates and Status

Dec 02, 2013

02/12/2033

09/18/2025 19:00:01